echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 724 pharmaceutical hospitals are not procured (with list)

    724 pharmaceutical hospitals are not procured (with list)

    • Last Update: 2020-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The notice shows that according to the letter of Yunnan Provincial Medical Security Bureau on adjusting the price of the second batch of selected drugs with the generic name non-selected drugs, and the relevant reply letter of Yunnan Provincial State Organization for the centralized procurement and use of drugs to expand the price adjustment scheme of non-selected drugs (Cloud Medical Insurance (2019) No. 156), Yunnan Province, the second batch of national collection of non-selected drugs hanging network transactions related matters notice as follows: First, the second batch of non-selected drugs hanging network results hanging network principle is as follows: (1) in line with the reporting requirements of Yunnan Province, the second batch of national collection of non-selected drugs, medical institutions can be directly purchased according to the list price, can also be bargained for procurement.
    (2) if the price is not declared in accordance with the reporting requirements, the medical institution may bargain for the purchase.
    (iii) If more than 3 production enterprises have passed the conformity evaluation with the generic name of the drug selected, the products that have not passed the conformity evaluation will no longer be selected in the case of ensuring supply.
    that a total of 29 pharmaceutical products because of consistent evaluation of the production enterprises reached more than 3 were stopped procurement.
    (Photo Source: Medical Information Local Station) (IV) The online products will be officially launched on August 17, 2020 in Yunnan Province' drug centralized procurement platform drug trading system.
    The relevant enterprises shall carefully and carefully check the drug information (including the minimum preparation unit, the unit of price, the packaging unit, the quantity of packaging, the generic name, dosage form, specifications, the name of the enterprise, the notes, etc.).
    If the basic information of drugs changes, please send an authorized representative to hold the legal representative's authorization letter (original) and the authorized person's identity card (original) before 17:00 p.m. on August 14, 2020 (except for statutory holidays) to submit information modification application information to Room 601 of the trading building of 269 Kofa Road, Kunming High-rise District.
    , the second batch of national collection of selected drugs corresponding to the same generic name of the old winning drug, will be non-selected drugs after the network transaction to stop the registration of the network trading qualification.
    A total of 724 pharmaceutical trading qualifications, involving a large number of pharmaceutical companies, including Hangzhou Merca East Pharmaceutical Co., Ltd., Shi Pharmaceutical Group Euro-Italian Pharmaceutical Co., Ltd., Shanghai Xinyi Vision Pharmaceutical Co., Ltd., Northeast Pharmaceutical Shenyang First Pharmaceutical Co., Ltd.
    Before the reduction of the price of non-selected drugs and the cessation of the internet, the Yunnan Provincial Medical Security Bureau issued the "Programme for the Price Adjustment of The Central Purchase and Use of Non-Selected Drugs by Yunnan Provincial State Organizations", which provides for and notifies the central procurement and use of non-selected drugs by the State Organization for the centralized procurement and use of the pilot expansion of the non-selected drugs. The
    document stipulates the prices of drugs selected by the State for centralized procurement and use of selected drugs with generic names in the pilot expansion, and mainly requires as follows: (1) The state centralized procurement of selected drugs in non-Yunnan Province supply areas of the production enterprises in accordance with the national centralized procurement of selected prices to apply directly online.
    (2) Other specifications for the centralized procurement of selected drugs by the State shall be applied for directly on the Internet after the enterprise has changed the price according to the differential price rule.
    (3) The remaining pharmaceutical production enterprises with the same generic name as the selected drugs may apply for registration according to the minimum actual purchase price (not higher than the purchase price of the pilot city of 4-7) of the national provincial centralized procurement platform for drugs with the same factory regulations.
    (iv) According to the Opinions on the Conduct of Conformity Evaluation of the Quality and Efficacy of Generic Drugs (State Office Issued No. 8 of 2016) and The Implementation Opinion of the General Office of the Yunnan Provincial People's Government on Further Reform and Improvement of the Policy on the Use of Drug Production and Circulation (No. 8 of 2019) require that more than three production enterprises with the generic name of the selected drug no longer use varieties that have not passed the consistent evaluation in order to ensure supply.
    (5) By adjusting the declaration of reduced prices of drugs, medical institutions may purchase directly at the online price, or they may bargain for the purchase.
    (6) The declaring enterprise is responsible for the legality and authenticity of the declared information.
    if there is a price false report, understrealing, or after the price has changed, not according to the provisions of the application for adjustment of drugs, suspended trading until the cancellation of the registration of the network.
    That is to say, if the drug is not selected, either according to the national collection price directly to the network, or according to the lowest actual purchase price in the country (not higher than the purchase price of the pilot city of 4-7) to apply for the network, if the price is not adjusted, will be suspended until the cancellation of the list price, abandoned the Yunnan market.
    sets of unseeded varieties, fate is worrying According to incomplete statistics, there have been at least 15 provinces such as Jiangxi, Zhejiang, the latest introduction of the collection policy to provide: for 3 products that have passed the consistent evaluation, suspended the online procurement qualification of products that have not passed the consistent evaluation;
    not entered the provincial drug centralized procurement platform online trading, temporarily not included in the provincial drug centralized procurement.
    Especially in Heilongjiang, Jiangxi, Jiangsu, Hubei, Guangxi and other provinces, has announced that some of the non-conformity evaluation of varieties, due to the same varieties of drugs over-conformity evaluation of the production enterprises reached more than 3, suspended their trading qualifications.
    If a consistent evaluation is said, it is to solve the survival problem of enterprises, then, as long as their own varieties are included in the collection range, even if the winning bid, the gradient price reduction to the winning bid price is also the fate it has to face.
    fengyun drug talk data show that the market share of the original research products under the national mining mechanism fell across the board, 2017-2019 data comparison decline of more than 60%, the terminal hospital market decline significantly.
    Relative to the decline in selected products and original research, the decline in domestic competition for selected products in the catalogue was staggering, with a decline of more than 80% in 2017-2019, including sales figures for the first quarter of 2019.
    to some extent, under the rules of national mining, the market share of unseeded products and unre rated products in clinical terminals will be seriously affected, Yunnan Province is a typical case.
    (Photo: Medical Information Local)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.